Next Generation
wound care for animals

RAVIMUS VET is an advanced sterile wound dressing for animals, featuring innovative nanofiber technology. It's designed to help wounds heal better and prevent the bacterial growth.

The wound contact layer of Ravimus Vet goes on the wound and is made from natural silk nanofibers with a touch of copper and silver nanoparticles. The absorbent layer soaks up moisture and is made from eco-friendly cellulose foam.

Ravimus Vet supports the wound healing process by keeping the right amount of moisture around the wound and absorbing any extra fluids.

Product code

Size

Box

Ravimus5

5 × 5 cm

5 pcs

Ravimus10

10 × 10 cm

10 pcs

Ravimus Vet is available in the Baltics.

Tallinn:
Tatari Loomakliinik
Tatari 3, Tallinn
Tel. +372 646 7084
View on Google Maps

Tartu:
Eesti Maaülikooli apteek
Kreutzwaldi 62, Tartu
Tel. +372 731 3204
View on Google Maps

Or visit our distributor.

For other locations contact info@nanordica.com

Features

Acts as a shield

Inactivates bacteria

Accelerated wound closure

Promotes skin regeneration

Improves the life quality of animals

Reduces pain & suffering

Inactivates efficiently microbes including antibiotic-resistant bacteria

Pseudomonas aeruginosa ATCC 27853
Staphylococcus aureus NCTC 12493 MRSA(+)
Escherichia coli ESBL(+)
Klebsiella pneumoniae ATCC 700603 ESBL(+)
Enterococcus faecalis ATCC 51299 VRE(+)
Staphylococcus epidermidis ATCC 12228
Fungi Candida albicans

Tested by the North Estonia Medical Center according to ISO 20645: 2004

MODE OF ACTION

1. Dressing conforms to the wound bed

2. Attracts bacteria from the wound cavity

3. Inactivates bacteria on the antibacterial layer

4. Improves the wound healing

SCIENCE BEHIND OUR TECH

We rely on scientifically proven effectiveness of the Ravimus VET. Ravimus wound care technology was developed by scientists and medical doctors as a result of 20 years of research at the National Institute of Chemical Physics and Biophysics, Estonia.

OUR publications

Interview · Anna-Liisa Kubo

Metal Inorganic Nanoparticles and Their Application in Wound Care

Article · Scientific Report Magazine

Synergistic antibacterial effect of copper and silver nanoparticles and their mechanism of action

PhD Thesis · Grigory Vasiliev

Synergistic Mechanisms and Toxicity Profiles of Silver and Copper Nanoparticles for the Development of Novel Antimicrobial Materials

Article · Pharmaceutics Journal

Antibacterial and Antiviral Effects of Ag, Cu and Zn Metals, Respective Nanoparticles and Filter Materials Thereof against Coronavirus SARS-CoV-2 and Influenza A Virus

Article · Springer Link Journal

Surface carboxylation or PEGylation decreases CuO nanoparticles’ cytotoxicity to human cells in vitro without compromising their antibacterial properties

Patent Application

Increased antimicrobial effectiveness (synergy) of silver and copper compounds and medicinal use of their combinations

Facts

Internal laboratory data from wound infection model. Less is better.

Our technology inactivates bacterial infection 8× better compared to traditional Ag+ dressings.

Our technology improves wound healing considerably after already 1 week of treatment.

Data from clinical study.

Improved growth of skin cells illustration

Internal laboratory data (scratch assay).

Cu supports migration of skin cells (fibroblasts) and wound closure.

The Nanordica team continues its scientific research on studying the synergistic effect of nanoparticles. We are confident that this technology will revolutionize infection control.

Team

Most of the Nanordica scientists have pets and they have experienced the sad feeling when an animal has a wound or trauma. An animal with a wound is stressed and traumatized. To help pets recover faster and wounds heal more quickly, they created a wound dressing that minimizes trauma and rapidly repairs the wound.

Olesja Bondarenko, PhD

Chief Executive Officer

Meelis Kadaja, PhD, MBA

Chief Business Officer

Anna-Liisa Kubo, PhD

Chief Innovation Officer

Andres Valkna, PhD

Chief Technology Officer

Einar Kaljuveer, Msc

Product Developer

Mart Roosimaa, MD

Medical Scientific Liaison

Grigory Vasiliev, MD, PhD

Chief Clinical Officer

Next Generation
wound care for animals